<DOC>
	<DOCNO>NCT00425620</DOCNO>
	<brief_summary>The primary objective study evaluate safety efficacy Amphotericin B suspension versus placebo complete resolution key chronic sinusitis symptom 16 week treatment patient refractory , postsurgical CS .</brief_summary>
	<brief_title>Amphotericin B Suspension Refractory Chronic Sinusitis</brief_title>
	<detailed_description />
	<mesh_term>Sinusitis</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Amphotericin B</mesh_term>
	<mesh_term>Liposomal amphotericin B</mesh_term>
	<criteria>Has diagnosis refractory , postsurgical chronic sinusitis Has document history chronic sinusitis symptom 12 week A CT scan show certain level mucosal thicken least 1 maxillary sinus An endoscopy document presence inflammation absence stage 4 polyps Ability comply study requirement include ability administer nasal lavage twice daily 4 month Females childbearing potential must use adequate birth control method plan get pregnant course study . Ability read speak English Has hypersensitivity Amphotericin B compound study medication Is immunosuppressed patient receive disease modify agent Has acute upper low respiratory illness Has acute exacerbation chronic sinusitis within 1 month prior randomization Has use systemic antibiotic therapy reason acute sinusitis within 3 week prior randomization Has use antibiotic therapy acute complication chronic sinusitis within 1 month prior randomization Has orbital central nervous system complication Has acute asthma study initiation Began use nasal corticosteroid dosage change within 3 month prior randomization Has take dose oral intravenous steroid treat condition asthma within 1 month prior randomization Has use systemic antifungal therapy within 3 month prior randomization Has use intranasal antifungal therapy chronic sinusitis within 3 month prior randomization Currently clinically significant deviate nasal septum remedied surgery Has anatomical abnormality would significantly obstruct nasal passage Has cystic fibrosis Is pregnant Has stage 4 polyposis Has significant medical condition doctor 's opinion could affect patient 's participation trial Has use investigational product within 1 month study initiation Has history cancer treat squamous cell basal cell carcinoma skin full remission least 5 year prior study initiation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>Chronic Sinusitis</keyword>
	<keyword>Chronic Rhinosinusitis</keyword>
</DOC>